Pipeline

Optiscan: Pioneering the Future of Imaging

Optiscan's advanced imaging technology delivers unparalleled insights by providing live, single-cell imaging with sub-cellular resolution. This revolutionary technology empowers clinicians and pathologists with immediate feedback, fostering collaboration and driving improved patient outcomes. By enabling unlimited sampling and continuous disease monitoring, our solutions streamline clinical workflows and redefine healthcare standards.

Shaping the Future of Healthcare

Optiscan is at the forefront of innovation, exploring a vast array of applications for our transformative technology.

Telepathology: Revolutionizing remote diagnostics and interoperative care through real-time digital pathology. Enabling seamless collaboration between surgeons and pathologists, regardless of location, for faster and more accurate decision-making.

Artificial Intelligence (AI): Enhancing image analysis with AI-powered identification and diagnostics. Accelerating diagnosis, improving accuracy, and increasing efficiency.

Robotics: Integrating our imaging technology with robotic systems for unprecedented precision and control in surgical procedures. Delivering enhanced outcomes and reduced risks.

Next-Generation Gastrointestinal (GI) Applications: Transforming GI diagnostics and treatment through detailed, real-time tissue visualization. Enabling earlier detection, more accurate diagnoses, and improved treatment efficacy.

Beyond these key areas, we are actively exploring opportunities in oral, cervical, surgical, and veterinary medicine. Our commitment to innovation extends to developing biopsy channel-compatible devices, integrating with robotic systems, and advancing image-guided molecular surgery.

Through ongoing in-house research and collaboration with academic institutions and industry partners, Optiscan is dedicated to pushing the boundaries.

Future Possibilities

Optiscan is working on innovating and commercialising new technology solutions that enable informed decisions for healthcare globally and establish a new standard of care in digital pathology and precision image guided surgery.

Learn more about the potential of Optiscan technology within the operating theatre with Prof. Mark Preul (Director of Neurosurgery Research at the Barrow Neurological Institute, USA).